Task: Answer the multiple-choice question.
Question: Which drug exhibits a -0.171% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Nn1c(SCC(=O)NC2CCCCC2)nnc1-c1ccccc1
b) O=C(Nc1nnc(COc2ccccc2F)s1)Nc1ccccc1F
c) N#CCCN1CCN(S(=O)(=O)c2ccc(S(=O)(=O)NCC3CCCO3)cc2)CC1
Answer: a. Nn1c(SCC(=O)NC2CCCCC2)nnc1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nn1c(SCC(=O)NC2CCCCC2)nnc1-c1ccccc1
Nn1c(SCC(=O)NC2CCCCC2)nnc1-c1ccccc1
2-[(4-amino-5-phenyl-1,2,4-triazol-3-yl)sulfanyl]-N-cyclohexylacetamide